The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: Analysis employing a family based approach

P.G. McGlinchey, M.S. Spence, Christopher Patterson, Adrian Allen, G. Murphy, Damian Fogarty, A Evans, Pascal McKeown

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Matrix metalloproteinase-3 (MMP-3) has been proposed as an important mediator of the atherosclerotic process. The possible role of the functional -1612(.)5A/6A polymorphism of the MMP-3 gene in the susceptibility to ischaemic heart disease (IHD) was investigated in a well-defined Irish population using two recently described family based tests of association. One thousand and twelve individuals from 386 families with at least one member prematurely affected with IHD were genotyped. Using the combined transmission disequilibrium test (TDT)/sib-TDT and the pedigree disequilibrium test (PDT), no association between the MMP-3 -1612 5A/6A polymorphism and IHD was found. Our data demonstrate that, in an Irish population, the MMP-3 -1612 5A/6A polymorphism is not associated with IHD.
Original languageEnglish
Pages (from-to)289-294
Number of pages6
JournalDisease markers
Volume20(6)
Issue number6
Publication statusPublished - 2004

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: Analysis employing a family based approach'. Together they form a unique fingerprint.

  • Cite this

    McGlinchey, P. G., Spence, M. S., Patterson, C., Allen, A., Murphy, G., Fogarty, D., Evans, A., & McKeown, P. (2004). The matrix metalloproteinase-3 (MMP-3) 5A/6A promoter polymorphism is not associated with ischaemic heart disease: Analysis employing a family based approach. Disease markers, 20(6)(6), 289-294.